
Venkataraman Balasubramanian
Examiner (ID: 9057, Phone: (571)272-0662 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1624, 1611 |
| Total Applications | 2999 |
| Issued Applications | 2022 |
| Pending Applications | 254 |
| Abandoned Applications | 724 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11649122
[patent_doc_number] => 20170145020
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-25
[patent_title] => '5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS,COMPOSITIONS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/424536
[patent_app_country] => US
[patent_app_date] => 2017-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 114246
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15424536
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/424536 | 5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS,COMPOSITIONS AND METHODS OF USE THEREOF | Feb 2, 2017 | Abandoned |
Array
(
[id] => 11821811
[patent_doc_number] => 20170210748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => 'ASK 1 INHIBITING PYRROLOPYRIMIDINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 15/420000
[patent_app_country] => US
[patent_app_date] => 2017-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 26403
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15420000
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/420000 | ASK 1 INHIBITING PYRROLOPYRIMIDINE DERIVATIVES | Jan 29, 2017 | Abandoned |
Array
(
[id] => 15816405
[patent_doc_number] => 10633368
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-28
[patent_title] => Voriconazole intermediate and voriconazole synthesis method
[patent_app_type] => utility
[patent_app_number] => 16/064003
[patent_app_country] => US
[patent_app_date] => 2017-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2843
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 313
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16064003
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/064003 | Voriconazole intermediate and voriconazole synthesis method | Jan 15, 2017 | Issued |
Array
(
[id] => 15423067
[patent_doc_number] => 10544449
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-28
[patent_title] => Bis-biotinylation tags
[patent_app_type] => utility
[patent_app_number] => 15/399931
[patent_app_country] => US
[patent_app_date] => 2017-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 21389
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15399931
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/399931 | Bis-biotinylation tags | Jan 5, 2017 | Issued |
Array
(
[id] => 11753720
[patent_doc_number] => 09711740
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-18
[patent_title] => 'Organometallic complex, light-emitting element, light-emitting device, electronic device, and lighting device'
[patent_app_type] => utility
[patent_app_number] => 15/392048
[patent_app_country] => US
[patent_app_date] => 2016-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 18
[patent_no_of_words] => 20175
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15392048
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/392048 | Organometallic complex, light-emitting element, light-emitting device, electronic device, and lighting device | Dec 27, 2016 | Issued |
Array
(
[id] => 11568554
[patent_doc_number] => 20170107194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-20
[patent_title] => 'THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 15/392681
[patent_app_country] => US
[patent_app_date] => 2016-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 97686
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15392681
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/392681 | Therapeutically active compounds and their methods of use | Dec 27, 2016 | Issued |
Array
(
[id] => 13777763
[patent_doc_number] => 20190002420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => PROCESS AND INTERMEDIATES FOR PREPARATION OF THIAZINE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 16/062955
[patent_app_country] => US
[patent_app_date] => 2016-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9693
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16062955
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/062955 | PROCESS AND INTERMEDIATES FOR PREPARATION OF THIAZINE DERIVATIVES | Dec 21, 2016 | Abandoned |
Array
(
[id] => 11542616
[patent_doc_number] => 20170096440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-06
[patent_title] => 'NOVEL ACTIVATORS OF GLUCOKINASE'
[patent_app_type] => utility
[patent_app_number] => 15/384226
[patent_app_country] => US
[patent_app_date] => 2016-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75162
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15384226
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/384226 | Activators of glucokinase | Dec 18, 2016 | Issued |
Array
(
[id] => 11542616
[patent_doc_number] => 20170096440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-06
[patent_title] => 'NOVEL ACTIVATORS OF GLUCOKINASE'
[patent_app_type] => utility
[patent_app_number] => 15/384226
[patent_app_country] => US
[patent_app_date] => 2016-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75162
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15384226
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/384226 | Activators of glucokinase | Dec 18, 2016 | Issued |
Array
(
[id] => 12448299
[patent_doc_number] => 09981951
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-29
[patent_title] => Crystalline and amorphous forms of Olaparib
[patent_app_type] => utility
[patent_app_number] => 15/382985
[patent_app_country] => US
[patent_app_date] => 2016-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 2177
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15382985
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/382985 | Crystalline and amorphous forms of Olaparib | Dec 18, 2016 | Issued |
Array
(
[id] => 11542616
[patent_doc_number] => 20170096440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-06
[patent_title] => 'NOVEL ACTIVATORS OF GLUCOKINASE'
[patent_app_type] => utility
[patent_app_number] => 15/384226
[patent_app_country] => US
[patent_app_date] => 2016-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75162
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15384226
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/384226 | Activators of glucokinase | Dec 18, 2016 | Issued |
Array
(
[id] => 11542616
[patent_doc_number] => 20170096440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-06
[patent_title] => 'NOVEL ACTIVATORS OF GLUCOKINASE'
[patent_app_type] => utility
[patent_app_number] => 15/384226
[patent_app_country] => US
[patent_app_date] => 2016-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75162
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15384226
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/384226 | Activators of glucokinase | Dec 18, 2016 | Issued |
Array
(
[id] => 11706136
[patent_doc_number] => 20170174636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'SOLID FORMS OF SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 15/381414
[patent_app_country] => US
[patent_app_date] => 2016-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 23744
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15381414
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/381414 | Solid forms of substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds | Dec 15, 2016 | Issued |
Array
(
[id] => 11901030
[patent_doc_number] => 09770450
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-26
[patent_title] => '4-OXO-3,4-dihydro-1,2,3-benzotriazine as modulators of GPR139'
[patent_app_type] => utility
[patent_app_number] => 15/382490
[patent_app_country] => US
[patent_app_date] => 2016-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28788
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15382490
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/382490 | 4-OXO-3,4-dihydro-1,2,3-benzotriazine as modulators of GPR139 | Dec 15, 2016 | Issued |
Array
(
[id] => 13222685
[patent_doc_number] => 10125107
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2018-11-13
[patent_title] => Carboxylic acid ester compound having polymerizable functional group and fluorine atom group, and method for producing same
[patent_app_type] => utility
[patent_app_number] => 15/778937
[patent_app_country] => US
[patent_app_date] => 2016-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2604
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15778937
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/778937 | Carboxylic acid ester compound having polymerizable functional group and fluorine atom group, and method for producing same | Dec 15, 2016 | Issued |
Array
(
[id] => 16533257
[patent_doc_number] => 10875840
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-29
[patent_title] => Methods for inducing bioorthogonal reactivity
[patent_app_type] => utility
[patent_app_number] => 16/062423
[patent_app_country] => US
[patent_app_date] => 2016-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12992
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16062423
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/062423 | Methods for inducing bioorthogonal reactivity | Dec 14, 2016 | Issued |
Array
(
[id] => 16351794
[patent_doc_number] => 10792285
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-06
[patent_title] => Stabilized pharmaceutical composition containing pemetrexed or pharmaceutically acceptable salt thereof
[patent_app_type] => utility
[patent_app_number] => 16/061450
[patent_app_country] => US
[patent_app_date] => 2016-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5220
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16061450
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/061450 | Stabilized pharmaceutical composition containing pemetrexed or pharmaceutically acceptable salt thereof | Dec 12, 2016 | Issued |
Array
(
[id] => 14963007
[patent_doc_number] => 20190308981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => HYDROBROMIDE OF BENZODIAZEPINE DERIVATIVE, PREPARATION METHOD AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/467866
[patent_app_country] => US
[patent_app_date] => 2016-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5488
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16467866
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/467866 | Hydrobromide of benzodiazepine derivative, preparation method and use thereof | Dec 12, 2016 | Issued |
Array
(
[id] => 11690826
[patent_doc_number] => 20170166542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-15
[patent_title] => 'Process for the Synthesis of Sulfones and Sulfonamides'
[patent_app_type] => utility
[patent_app_number] => 15/372778
[patent_app_country] => US
[patent_app_date] => 2016-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10661
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15372778
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/372778 | Process for the synthesis of sulfones and sulfonamides | Dec 7, 2016 | Issued |
Array
(
[id] => 11668412
[patent_doc_number] => 20170157132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => 'METHODS OF TREATMENT OF MALIGNANCIES'
[patent_app_type] => utility
[patent_app_number] => 15/368439
[patent_app_country] => US
[patent_app_date] => 2016-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 37874
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15368439
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/368439 | Methods of treatment of malignancies | Dec 1, 2016 | Issued |